Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Collaborative Defining the Natural History of Inborn errors of Metabolism
Genetic Analysis of Oral Streptococcal Biofilm Formation
Trans-Dominant Mutant Repressors of HIV-1 Replication
Endogenous Formation of Methylamines
High Resolution NMR in Solids
Recently added grants:
Regulation of spore peptidoglycan modification
Continuous Therapeutic Drug Monitoring of Antibiotics in CRRT
Neural circuit basis for neurovascular coupling
Serotonergic modulation of excitatory synapse formation and maturation during development
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67184-3-0-1
Application #
7574882
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hosp Pittsburgh/Upmc Health Sys
$182,089
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Lakshmanan, Krishnamurti /
$236,644
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant